Coming Events

Admescope actively participates in many international Life Sciences conferences. See below for some of the upcoming events where you can meet us and discuss your R&D services needs.

  • 15th Drug Discovery Strategic Summit 8-9 May 2024, Boston, Massachusetts

    The 15th Drug Discovery Strategic Summit (DDSS) provides a forum for innovative ideas to meet actionable implementation. DDSS guides Drug Discoveries with strategic agility, allowing you to manage evolving areas with foresight and innovation. This Summit captures the core of panel discussions led by industry leaders, one-to-one meetings, an immersive display of cutting-edge solutions, innovative keynote presentations, dedicated networking hours, and insightful speakers and poster sessions. DDSS welcomes you to embark on a transformative journey that will equip you to lead the evolution of Drug Discoveries with precision and skill. https://ddss.agilefalconsg.com/

  • BIO KOREA 2024 Internationl Convention 8-10 May 2024, Coex, Seoul

    The 19th BIO KOREA will be held on May 8-10, 2024 at Ceox, Seoul. Through various programs of BIO KOREA 2024 including Business Partnering, Invest Fair, Exhibition, and Conference, exchange the newest bio-health trends and technology as well as get the global expansion business opportunity with various international academics, professionals, and CEOs of the global bio-health field!

  • TIDES USA 14-15 May 2024, Boston, Massachusetts

    The TIDES conference scientific agenda includes 150+ of the industry’s top scientists to present the latest science and industry updates across the entire spectrum from discovery, preclinical, clinical development through CMC, Manufacturing and commercialization of therapeutics and vaccines for oligos, peptides, mRNA and genome editing products.

  • Trends in Metabolic Studies of Pharmaceutical Drugs 22 May 2024, Stockholm

    This meeting is for those responsible for the non-clinical (pre-clinical) development of a drug (all modalities except ATMP) in small- and medium-sized companies. In particular, industry or academic scientists who are active in studying the metabolism of drugs and/or developing bioanalytical methods to be employed in metabolism studies will be interested in the content of this workshop.

  • Oxford Global Drug Discovery Europe 2024 22-23 May, 2024, Basel, Switzerland

    Admescope is excited to participate in Discovery Europe 2024. This year, the event will feature the co-location of the 22nd Annual Drug Discovery Summit & Discovery Chemistry Europe alongside the 5th Annual Neuroscience Drug Development Europe Congresses. See you in Basel!

  • New Era of ADME and Beyond (NE-ADME 2024) 13 June 2024, Boston, Massachusetts

    The NE-ADME meeting will be held on June 13th at Merck Laboratories. Admescope is a sponsor of the event. The event includes several presentations, divided into three sessions, each focusing on the themes: ‘Complex Models to Support Drug Development’, ‘PK/PD for New Modalities’ and ‘Advanced Tools to Support Drug Discovery & Development’. https://www.bostonsociety.org/NE-ADME/

  • 50th DMDG Open Meeting 2024 2-4 September 2024, Heslington Campus East & Campus West, University of York, UK

    Team Admescope is participating in the 50th DMDG Open Meeting, which is scheduled for September 2nd to 4th, 2024. The event will take place at Heslington Campus East, University of York. The meeting will spend some time looking back at 50 years of Open Meetings and the contributions made by the DMDG to ADME/DMPK science of 5 decades in addition to looking forward to the next 50 years of contribution.

  • EUROTOX 2024 8-11 September 2024, The Tivoli Congress Center, Copenhagen, Denmark

    Meet us at Eurotox 2024, the 58th Congress of the European Societies of Toxicology, organized by the Danish Society of Toxicology and Pharmacology in Copenhagen, Denmark. With a focus on the theme “Toxicology – A Quest for safe Chemicals and Medicines”, this event explores critical topics such as safety of drugs and environmental chemicals, advanced technologies, personalized medicine, and the health impacts resulting from chemical exposure on human health, as well as safety concerns related to climate change.